Skip to main content
It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.
Hypercholesterolemia
- Comparing simvastatin & atorvastatin for the treatment of hypercholesterolemia
- Rosuvastatin versus simvastatin for the treatment of hypercholesterolemia
- Comparing simvastatin to ezetimibe for the treatment of hypercholesterolemia
- Comparing atorvastatin to ezetimibe for the treatment of hypercholesterolemia
- Comparing ezetimibe/simvastatin combination therapy vs. simvastatin monotherapy for the treatment of hypercholesterolemia
- Rosuvastatin versus atorvastatin for the treatment of hypercholesterolemia
- Comparing ezetimibe/simvastatin combination therapy vs. atorvastatin monotherapy for the treatment of hypercholesterolemia
- Fenofibrate versus atorvastatin for the treatment of hypercholesterolemia
- Extended-release niacin vs ezetimibe for the treatment of hypercholesterolemia
- Extended-release niacin/simvastatin vs simvastatin monotherapy for the treatment of hypercholesterolemia
- Pitavastatin versus atorvastatin for the treatment of hypercholesterolemia
- Comparing ezetimibe/ atorvastatin combination therapy vs. atorvastatin monotherapy for the treatment of hypercholesterolemia
- Comparing alirocumab plus atorvastatin versus atorvastatin plus ezetimibe for lowering low-density lipoprotein cholesterol (LDL-C)
- Comparing alirocumab plus atorvastatin versus a double dose of atorvastatin for lowering low-density lipoprotein cholesterol (LDL-C)
Hypertension
- Comparing the treatment of hypertension with atenolol and aetoprolol
- Comparing the treatment of hypertension with benazepril and amlodipine
- Comparing candesartan to amlodipine for the treatment of hypertension
- Amlodipine vs. losartan/hydrochloriazide for treating hypertension
- Amlodipine vs. valsartan/hydrochloriazide for treating hypertension
- Amlodipine vs. atenolol for treating hypertension
- Comparing olmesartan to ramipril in the treatment of hypertension
- Indapamide SR vs. candesartan and amlodipine for the treatment of hypertension
- Amlodipine with benazepril vs. benazepril with hydrochlorothiazide for treating hypertension
- Comparing the effect atenolol vs metoprolol succinate on the vascular outcomes of patients with hypertension
Heart disease & other cardiovascular topics
- Telmisartan, ramipril, or both for treating patients at risk for vascular events
- Comparing prasugrel versus clopidogrel to treat Acute Coronary Syndromes
- Comparing clopidogrel and aspirin to aspirin for the prevention of future atherothrombotic events
- Everolimus-eluting stents vs. paclitaxel-eluting stents for treating coronary artery disease
- Comparing ticagrelor to clopidogrel for treating acute coronary syndromes
- Comparing fondaparinux to enoxaparin in patients in the treatment of acute coronary syndromes
- Valsartan vs. captopril for treatment after a myocardial infarction
- Valsartan, vs. captopril & valsartan for treatment after a myocardial infarction
- Captopril vs. captopril & valsartan for treatment after a myocardial infarction
- Dabigatran vs. warfarin in the treatment of atrial fibrillation
- Apixaban vs. warfarin for the treatment of atrial fibrillation
- Aspirin vs. warfarin for preventing strokes
- Dabigatran vs. warfarin in the treatment of venous thromboembolism
- Edoxaban vs. warfarin in the treatment of atrial fibrillation
- Rivaroxaban vs. warfarin in the treatment of atrial fibrillation
- Pantoprazole vs. esomeprazole on the anti-platelet effects of clopidogrel
- Comparing amiodarone to sotalol for the treatment of atrial fibrillation
- Comparing apixaban to warfarin for the treatment of atrial fibrillation
- Amiodarone vs. sotalol in the treatment of atrial fibrillation
- Comparing fondaparinux to enoxaparin for treating acute coronary syndromes
- Nesiritide vs. nitroglycerin for treating heart failure
- Clopidogrel & omeprazole vs. clopidogrel alone for treating coronary artery disease
- Everolimus-eluting stents compared to sirolimus-eluting stents for treating coronary artery disease
- Aspirin + warfarin versus aspirin alone for treating acute coronary syndromes
- Everolimus-eluting stents compared to sirolimus-eluting stents in patients with diabetes
- Everolimus-eluting stents compared to paclitaxel-eluting stents in patients with diabetes
- Comparing aspirin to warfarin with Bleeding Complications in the treatment of acute coronary syndromes
- Comparing vorapaxar versus vorapaxar with clopidogrel for treating patients after non-ST-segment elevation acute coronary syndromes
- Plant compared with marine n-3 fatty acid effects on cardiovascular risk factors and outcomes
- Bivalirudin versus heparin for treating myocardial infarction
